109 related articles for article (PubMed ID: 11410253)
1. Molecular dynamics of point mutated I-A(k) molecules expressed on lymphocytes.
Munnelly HM; Brady CJ; Hagen GM; Horvat RD; Wade WF; Roess DA; Barisas BG
Immunol Lett; 2001 Jul; 77(3):187-96. PubMed ID: 11410253
[TBL] [Abstract][Full Text] [Related]
2. Mutations in MHC class II dimer of dimers contact residues: effects on antigen presentation.
Nydam T; Wade TK; Yadati S; Gabriel JL; Barisas BG; Wade WF
Int Immunol; 1998 Aug; 10(8):1237-49. PubMed ID: 9723711
[TBL] [Abstract][Full Text] [Related]
3. Rotational and lateral dynamics of I-A(k) molecules expressing cytoplasmic truncations.
Munnelly HM; Brady CJ; Hagen GM; Wade WF; Roess DA; Barisas BG
Int Immunol; 2000 Sep; 12(9):1319-28. PubMed ID: 10967027
[TBL] [Abstract][Full Text] [Related]
4. Mutations in specific I-A(k) alpha(2) and beta(2) domain residues affect surface expression.
Lang ML; Yadati S; Seeley ES; Nydam T; Wade TK; Gabriel JL; Yeaman G; Barisas BG; Wade WF
Int Immunol; 2000 Jun; 12(6):777-86. PubMed ID: 10837405
[TBL] [Abstract][Full Text] [Related]
5. Truncation of the A alpha chain of MHC class II molecules results in inefficient antigen presentation to antigen-specific T cells.
Wade WF; Ward ED; Rosloniec EF; Barisas BG; Freed JH
Int Immunol; 1994 Oct; 6(10):1457-65. PubMed ID: 7826938
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of molecules involved in antigen presentation: effects of fixation.
Barisas BG; Wade WF; Jovin TM; Arndt-Jovin D; Roess DA
Mol Immunol; 1999 Aug; 36(11-12):701-8. PubMed ID: 10593509
[TBL] [Abstract][Full Text] [Related]
7. Induction of dendritic cell costimulator molecule expression is suppressed by T cells in the absence of antigen-specific signalling: role of cluster formation, CD40 and HLA-class II for dendritic cell activation.
McLellan AD; Heiser A; Hart DN
Immunology; 1999 Oct; 98(2):171-80. PubMed ID: 10540215
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of the antigen binding region of an MHC class II molecule.
Rosloniec EF; Beard KS; Freed JH
Mol Immunol; 1993 Apr; 30(5):491-501. PubMed ID: 7681933
[TBL] [Abstract][Full Text] [Related]
9. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.
Kjer-Nielsen L; Perera JD; Boyd LF; Margulies DH; McCluskey J
J Immunol; 1990 Apr; 144(8):2915-24. PubMed ID: 1969876
[TBL] [Abstract][Full Text] [Related]
10. The Ia.2 epitope defines a subset of lipid raft-resident MHC class II molecules crucial to effective antigen presentation.
Busman-Sahay K; Sargent E; Harton JA; Drake JR
J Immunol; 2011 Jun; 186(12):6710-7. PubMed ID: 21543648
[TBL] [Abstract][Full Text] [Related]
11. Salt bridge residues between I-Ak dimer of dimers alpha-chains modulate antigen presentation.
Yadati S; Nydam T; Demian D; Wade TK; Gabriel JL; Barisas BG; Wade WF
Immunol Lett; 1999 Mar; 67(1):47-55. PubMed ID: 10217205
[TBL] [Abstract][Full Text] [Related]
12. Impaired antigen presentation by murine I-Ad class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines.
Weenink S; Averdunk H; Boston T; Boswarva V; Guery JC; Adorini L; Mellins E; McCluskey J; Gautam AM
Int Immunol; 1997 Jun; 9(6):889-96. PubMed ID: 9199972
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the signaling function of MHC class II molecules during antigen presentation by B cells.
St Pierre Y; Watts TH
J Immunol; 1991 Nov; 147(9):2875-82. PubMed ID: 1680921
[TBL] [Abstract][Full Text] [Related]
14. The immune function of MHC class II molecules mutated in the putative superdimer interface.
Hayball JD; Lake RA
Mol Cell Biochem; 2005 May; 273(1-2):1-9. PubMed ID: 16013435
[TBL] [Abstract][Full Text] [Related]
15. I-Ak polymorphisms define a functionally dominant region for the presentation of hen egg lysozyme peptides.
Rosloniec EF; Vitez LJ; Beck BN; Buerstedde JM; McKean DJ; Landais D; Benoist C; Mathis D; Freed JH
J Immunol; 1989 Jul; 143(1):50-8. PubMed ID: 2786533
[TBL] [Abstract][Full Text] [Related]
16. Mutation of the invariant chain transmembrane region inhibits II degradation, prolongs association with MHC class II, and selectively disrupts antigen presentation.
Frauwirth K; Shastri N
Cell Immunol; 2001 May; 209(2):97-108. PubMed ID: 11446742
[TBL] [Abstract][Full Text] [Related]
17. CD40 associates with the MHC class II molecules on human B cells.
Léveillé C; Chandad F; Al-Daccak R; Mourad W
Eur J Immunol; 1999 Nov; 29(11):3516-26. PubMed ID: 10556806
[TBL] [Abstract][Full Text] [Related]
18. The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent.
Stebbins CC; Loss GE; Elias CG; Chervonsky A; Sant AJ
J Exp Med; 1995 Jan; 181(1):223-34. PubMed ID: 7807005
[TBL] [Abstract][Full Text] [Related]
19. Selective immunosuppression by administration of major histocompatibility complex class II-binding peptides. II. Preventive inhibition of primary and secondary in vivo antibody responses.
Guéry JC; Neagu M; Rodriguez-Tarduchy G; Adorini L
J Exp Med; 1993 May; 177(5):1461-8. PubMed ID: 8478615
[TBL] [Abstract][Full Text] [Related]
20. mAb against hen egg-white lysozyme regulate its presentation to CD4(+) T cells.
Guermonprez P; Lo-Man R; Sedlik C; Rojas MJ; Poljak RJ; Leclerc C
Int Immunol; 1999 Nov; 11(11):1863-72. PubMed ID: 10545490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
